Medicare Enrolled
Dr. Claudio Manubens, M.D.
Cardiovascular Disease · Davenport, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manubens from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manubens? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Manubens
Dr. Claudio Manubens is a cardiovascular disease in Davenport, FL, with 20 years in practice. Based on federal Medicare data, Dr. Manubens performed 16,848 Medicare services across 6,701 unique beneficiaries.
Between the years covered by Open Payments, Dr. Manubens received a total of $15,264 from 43 pharmaceutical and/or device companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Manubens is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $15,264 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,848
Medicare services
Top 2% in FL for cardiovascular disease
6,701
Unique beneficiaries
$148
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~842 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Home visit, established patient, moderate complexity | 2,538 | $93 | $250 |
| Nursing facility visit, low complexity | 2,070 | $55 | $135 |
| Contrast dye for imaging (iodine-based) | 1,990 | $0 | $1 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 1,701 | $29 | $86 |
| Office visit, established patient (20-29 min) | 1,268 | $63 | $217 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 534 | $40 | $104 |
| Regadenoson injection (Lexiscan) for heart stress test | 488 | $45 | $138 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 481 | $32 | $80 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 456 | $134 | $305 |
| Electrocardiogram (EKG), 12-lead | 443 | $10 | $37 |
| Office visit, established patient (30-39 min) | 419 | $93 | $264 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 355 | $8 | $20 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 334 | $59 | $163 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 264 | $89 | $275 |
| Echocardiogram, transthoracic | 235 | $131 | $485 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 232 | $38 | $84 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 187 | $17 | $67 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 177 | $726 | $2,495 |
| Home visit, established patient, low complexity | 160 | $52 | $163 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $48 | $188 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 132 | $324 | $1,050 |
| Remote pacemaker monitoring, 90 days | 129 | $21 | $76 |
| Review by radiologist of arm or leg artery image | 107 | $117 | $750 |
| Remote patient monitoring management, 20 min/month | 107 | $38 | $139 |
| Review by radiologist of both arms or legs arteries image | 88 | $125 | $762 |
| Office visit, established patient (10-19 min) | 82 | $38 | $142 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 77 | $90 | $375 |
| Review by radiologist of abdominal aorta image | 74 | $97 | $637 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 74 | $104 | $349 |
| New patient office visit (45-59 min) | 71 | $119 | $317 |
| Insertion of tube into vein, second order branch | 70 | $343 | $1,300 |
| Insertion of stent in vein with review by radiologist, initial vein | 70 | $2,621 | $6,699 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 65 | $136 | $443 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 65 | $80 | $292 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 60 | $941 | $2,519 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 59 | $31 | $127 |
| Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 58 | $140 | $369 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 55 | $476 | $3,176 |
| Cardiac catheterization | 53 | $579 | $2,181 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 53 | $15 | $50 |
| Removal of plaque and insertion of stents in arteries of leg | 50 | $7,408 | $20,000 |
| New patient office visit (30-44 min) | 50 | $60 | $281 |
| Remote patient monitoring device, 30 days | 50 | $38 | $139 |
| Hospital follow-up visit, moderate complexity | 49 | $64 | $179 |
| Initial hospital admission, moderate complexity | 45 | $104 | $341 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $47 | $185 |
| Removal of plaque and insertion of stents in artery of leg, initial vessel | 42 | $8,933 | $20,000 |
| Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | 41 | $101 | $296 |
| Review by radiologist of major lower body vein image | 40 | $89 | $623 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 34 | $647 | $2,823 |
| Initial psychiatric collaborative care management, first calendar month, first 70 minutes | 33 | $118 | $458 |
| Review by radiologist of abdominal artery image | 31 | $134 | $500 |
| Ultrasound of leg arteries or artery grafts | 30 | $170 | $507 |
| Ultrasound of both sides of head and neck blood flow | 27 | $133 | $449 |
| Insertion of stent in artery (except lower extremity, chest, heart, neck and brain) with review by radiologist, initial artery | 26 | $1,865 | $8,000 |
| Ultrasound of heart, follow-up | 26 | $69 | $243 |
| Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | 26 | $112 | $405 |
| Removal of plaque in artery of leg, each additional vessel | 25 | $810 | $2,000 |
| Insertion of stent in groin artery, initial vessel | 24 | $1,725 | $7,000 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 23 | $19 | $63 |
| Removal of plaque in artery of leg, initial vessel | 22 | $5,691 | $15,000 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 16 | $1,764 | $2,500 |
| Removal of plaque in arteries of leg | 15 | $5,323 | $15,000 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $19 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $627 | $1,481 |
| Insertion of tube in right heart chambers for measurement | 13 | $654 | $2,210 |
| Complete ultrasound study of arm and leg arteries | 11 | $88 | $318 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $78 | $342 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.3% high complexity
21.3% medium
74.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,264
Total received (2018-2024)
Avg $2,181/year across 7 years
Top 17% in FL for cardiovascular disease
43
Companies
421
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,725 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$540 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,742
2023$1,723
2022$1,286
2021$1,759
2020$1,535
2019$3,400
2018$3,819
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$3,057
BIOTRONIK INC.
$3,040
Amgen Inc.
$1,045
Janssen Pharmaceuticals, Inc
$981
Abbott Laboratories
$867
Novartis Pharmaceuticals Corporation
$590
Bard Peripheral Vascular, Inc.
$528
Astellas Pharma US Inc
$429
Medtronic, Inc.
$407
CVRx, Inc.
$376
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$372
Impulse Dynamics (USA) Inc.
$311
E.R. Squibb & Sons, L.L.C.
$309
AstraZeneca Pharmaceuticals LP
$302
Bayer HealthCare Pharmaceuticals Inc.
$245
Esperion Therapeutics, Inc.
$240
Merck Sharp & Dohme LLC
$213
Cook Medical LLC
$210
Actelion Pharmaceuticals US, Inc.
$209
PFIZER INC.
$181
Regeneron Healthcare Solutions, Inc.
$154
Smith+Nephew, Inc.
$127
Penumbra, Inc.
$120
Edwards Lifesciences Corporation
$114
SANOFI-AVENTIS U.S. LLC
$105
W. L. Gore & Associates, Inc.
$95
Gilead Sciences, Inc.
$82
United Therapeutics Corporation
$82
BARD PERIPHERAL VASCULAR, INC.
$80
Amarin Pharma Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Alnylam Pharmaceuticals Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$35
Philips Electronics North America Corporation
$25
HeartFlow, Inc.
$21
Lilly USA, LLC
$21
ATRICURE, INC.
$20
Lundbeck LLC
$20
Eisai Inc.
$16
Tactile Systems Technology Inc
$16
Adhera Therapeutics, Inc.
$16
Merck Sharp & Dohme Corporation
$15
ARALEZ PHARMACEUTICALS US INC.
$12
Top 3 companies account for 46.8% of total payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · 3F · AMPLATZER AMULET · AVEIR · Acticor · Acticor 7 VR-T DX · Adempas · Azure · BIOMONITOR · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CONFIRM RX · CROSSER · Confirm Rx · Cook Medical Angioplasty · CoreValve Evolut · Corlanor · Dayvigo · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Evera · FARXIGA · Flexitouch Plus · GORE VIABAHN Endoprosthesis with Heparin · GORE VIABAHN VBX Balloon Expandable Endo · GRAFIX PL · HAWKONE · INVOKANA · Indigo · JARDIANCE · LEQVIO · LEXISCAN · LIFESTREAM · LUTONIX · LifeVest · Lunderquist · MICRA · MITRACLIP · MOUNJARO · MULTAQ · Micra · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPTIMIZER · ORENITRAM · Optimizer · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESTALIA · REXULTI · Repatha · Resolute · Reveal LINQ · Rotarex · Santyl · Solia · TURBOHAWK · TYVASO · VENOVO · VERQUVO · VESICARE · VYNDAMAX · Vascepa · Verquvo · Visia AF · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $91 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
89
Per 100K population
11.7
County median income
$63,644
Nearest hospital
ADVENTHEALTH HEART OF FLORIDA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Manubens is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Manubens experienced with home visit, established patient, moderate complexity?
Based on Medicare claims data, Dr. Manubens performed 2,538 home visit, established patient, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manubens receive payments from pharmaceutical companies?
Yes. Dr. Manubens received a total of $15,264 from 43 companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manubens's costs compare to other cardiovascular diseases in Davenport?
Dr. Manubens's average Medicare payment per service is $148. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manubens) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Davenport
Browse cardiovascular diseases in Davenport ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology